Santiago Thibaud
Icahn School of Medicine at Mount Sinai
H-index: 11
North America-United States
Top articles of Santiago Thibaud
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
Blood Advances
2024/1/9
Santiago Thibaud
H-Index: 5
Immune Dynamics Associated with Patient Outcomes Identified By Multimodal Single-Cell Analysis in Multiple Myeloma Patients Receiving Talquetamab Monotherapy
Blood
2023/11/28
Bhaskar Upadhyaya
H-Index: 4
Santiago Thibaud
H-Index: 5
Multimodal Single-Cell Transcriptomic and Proteomic Correlatives of Patients Outcomes Following Anti-BCMA Cellular Therapy with Ciltacabtagene Autoleucel (Cilta-cel) in …
Blood
2023/11/28
Sherry Bhalla
H-Index: 11
Oliver Van Oekelen
H-Index: 3
Sridevi Rajeeve
H-Index: 2
Bhaskar Upadhyaya
H-Index: 4
Santiago Thibaud
H-Index: 5
Inflammatory Marker Levels, Age, Race and Prior Treatment Burden Independently Predict Delayed Hematologic Recovery after BCMA-Directed CART Therapy in Multiple Myeloma
Blood
2023/11/28
Santiago Thibaud
H-Index: 5
Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease
Blood
2023/11/28
Santiago Thibaud
H-Index: 5
Early and Consistent CRS Detection Using Wearable Device for Remote Patient Monitoring Following CAR-T Therapy in Relapsed/Refractory Multiple Myeloma (RRMM): Early Results of …
Blood
2023/11/28
Confirmed Pathogenic Germline Variants in Cancer Predisposition Genes Incidentally Detected in Somatic Genomic Profiling of Multiple Myeloma Patients
Blood
2023/11/28
Santiago Thibaud
H-Index: 5
Durable MRD and Imaging-Negative Remission≥ 5 Years Post-Therapy Predicts Long-Term Progression-Free Survival in Multiple Myeloma Patients-a Single-Center Observational Study
Blood
2023/11/28
Santiago Thibaud
H-Index: 5
Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy
Blood
2023/11/28
Santiago Thibaud
H-Index: 5
Timing of Vaccination Impacts Serological Response to COVID-19 Myeloma Patients after BCMA-Targeted CAR T
Blood
2023/11/28
Oliver Van Oekelen
H-Index: 3
Bhaskar Upadhyaya
H-Index: 4
Santiago Thibaud
H-Index: 5
Florian Krammer
H-Index: 68
IVIg use associated with ten-fold reduction of serious infections in multiple myeloma patients treated with anti-BCMA bispecific antibodies
Blood Cancer Discovery
2023/11/1
Santiago Thibaud
H-Index: 5
P-043 Leveraging wearable devices for remote patient monitoring facilitate earlier CRS detection following CAR-T therapy in relapsed/refractory multiple myeloma (RRMM): early …
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
Early detection of CRS after CAR-T therapy using wearable monitoring devices: Preliminary results in relapsed/refractory multiple myeloma (RRMM).
2023/6/1
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Blood advances
2023/3/28
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Blood
2023/2/16
Oliver Van Oekelen
H-Index: 3
Santiago Thibaud
H-Index: 5
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support
Bone Marrow Transplantation
2023/1
Santiago Thibaud
H-Index: 5
Gain of chr1q Portends Poor Outcomes in Multiple Myeloma Patients Treated with Venetoclax
Blood
2022/11/15
Santiago Thibaud
H-Index: 5
Immune recovery post BCMA CAR-T: Implications for infection prophylaxis and vaccinations
Blood
2022/11/15
Santiago Thibaud
H-Index: 5
Timing and nature of infections in multiple myeloma patients treated with anti-BCMA CAR-T cells
Blood
2022/11/15
Santiago Thibaud
H-Index: 5
Extramedullary Relapse Post CAR-T
Blood
2022/11/15
Santiago Thibaud
H-Index: 5
